June 21, 2022
Blog
-
CiteAb data supports the entry of Charles River into the S&P 500
Find out how the CiteAb experimental models dataset supports Charles River Laboratories entry into...June 14, 2022 -
One to watch: the CiteAb Multiplex Immunoassay Supplier Award winner!
Insights into the multiplex immunoassay market through the 2022 CiteAb Awards, celebrating suppliers succeeding...June 7, 2022 -
CiteAb’s introductory guide: western blotting alternatives
An introductory guide on the advancements to western blotting which can help overcome its...May 31, 2022 -
No longer live – We’re Hiring! Biologist wanted to join our team
No longer live Here at CiteAb we’re looking for a graduate with a bioscience...May 18, 2022 -
Announcing the JAGGAER-CiteAb partnership
Learn more about the JAGGAER-CiteAb partnership which will help researchers find and purchase the...May 17, 2022 -
Celebrating beautiful scientific imagery!
Putting a spotlight on the CiteAb 2022 Image of the Year winner: celebrating published...May 10, 2022 -
Leading antibody suppliers and products in cancer research
We analyse the leading antibody suppliers within the cancer research market, as well as...May 3, 2022 -
Celebrating industry leading environmental initiatives!
It is no secret that life science is a major contributor to the climate...April 26, 2022 -
Royal recognition for CiteAb with Queen’s Award for Innovation win!
We are absolutely thrilled to share with you that CiteAb have been awarded a...April 21, 2022
